Close Asset Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45K Hold
300
﹤0.01% 174
2026
Q1
$28K Hold
300
﹤0.01% 191
2025
Q4
$31K Sell
300
-160
-35% -$14.3K ﹤0.01% 195
2025
Q3
$29K Hold
460
﹤0.01% 195
2025
Q2
$24K Hold
460
﹤0.01% 195
2025
Q1
$20K Hold
460
﹤0.01% 191
2024
Q4
$14K Hold
460
﹤0.01% 205
2024
Q3
$11K Hold
460
﹤0.01% 218
2024
Q2
$13K Hold
460
﹤0.01% 216
2024
Q1
$9K Hold
460
﹤0.01% 221
2023
Q4
$12K Hold
460
﹤0.01% 203
2023
Q3
$14K Buy
460
+80
+21% +$2.81K ﹤0.01% 188
2023
Q2
$14K Buy
380
+60
+19% +$1.72K ﹤0.01% 209
2023
Q1
$8K Buy
320
+60
+23% +$1.71K ﹤0.01% 209
2022
Q4
$7K Buy
+260
New +$11.9K ﹤0.01% 175

Other funds holding GH

Close Asset Management's GH Position: Q2 2026 in Review

Close Asset Management held its Guardant Health (GH) position steady in Q2 2026 at 300 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #174.

Close Asset Management first reported a position in GH in Q4 2022 and has held it in 15 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Close Asset Management held 300 shares of Guardant Health worth $45K as of Q2 2026.
  • Close Asset Management left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up ﹤0.01% of Close Asset Management's portfolio in Q2 2026, its #174 holding.
  • Close Asset Management first reported a position in Guardant Health in Q4 2022 and has held it in 15 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Close Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.